UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
|
||
Washington, DC 20549
|
||
FORM 8-K/A
|
||
CURRENT REPORT
|
||
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
|
||
February 17, 2015
Date of report (Date of earliest event reported)
|
||
SUPPORT.COM, INC.
(Exact Name of Registrant as Specified in Charter)
|
||
Delaware
(State or Other
Jurisdiction
of Incorporation)
|
000-30901
(Commission File No.)
|
94-3282005
(I.R.S. Employer Identification No.)
|
900 Chesapeake Dr., Second Floor, Redwood City, CA 94063
(Address of Principal Executive Offices) (Zip Code)
|
||
(650) 556-9440
(Registrant’s telephone number, including area code)
|
||
N/A
(Former Name or Former Address, if Changed Since Last Report)
|
q
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
q
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
q
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
q
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
·
|
The exhibit indices to the Original Report, although indicating the Company’s request for confidential treatment for the attached document, did not indicate that portions of such document had been omitted pursuant to the request for confidential treatment; and
|
·
|
Exhibit 10.1 of the Original Report, although marking with three asterisks the specific portions of the document that the Company desires to be kept confidential pursuant to a request for confidential treatment, did not include a notice legend at the bottom of each appropriate page to indicate that such portions had been omitted pursuant to a request for confidential treatment.
|
SUPPORT.COM, INC.
|
|||
By:
|
/s/ Gregory J. Wrenn
|
||
Name:
|
Gregory J. Wrenn
|
||
Title:
|
SVP Business Affairs, General Counsel & Secretary
|
Exhibit No.
|
Description
|
|||
10.1
|
Statement of Work #4, between Comcast and Company, dated February 6, 2015.*
|
|||
* Portions of the exhibit have been omitted pursuant to a request for confidential treatment.
|